Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Small

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Blood|March 15, 1997
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiencyJ M Puck, A E Pepper, P S Henthorn, et al.
Bone Marrow Transplantation|July 1, 1997
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutisG Michel, F Boulad, T N Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcomaF Boulad, N A Kernan, M P LaQuaglia, et al.
Bone Marrow Transplantation|July 10, 2007
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host diseaseM-A Perales, N Ishill, W A Lomazow, et al.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA matchD M Ponce, A Gonzales, M Lubin, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Blood|March 15, 1997
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiencyJ M Puck, A E Pepper, P S Henthorn, et al.
Bone Marrow Transplantation|July 1, 1997
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutisG Michel, F Boulad, T N Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcomaF Boulad, N A Kernan, M P LaQuaglia, et al.
Bone Marrow Transplantation|July 10, 2007
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host diseaseM-A Perales, N Ishill, W A Lomazow, et al.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA matchD M Ponce, A Gonzales, M Lubin, et al.
Pageof 5